TNFSF10 and neoplasm: Interestingly, researchers artificially increased the tumor-tropism of TRAIL-expressing MSCs toward GD2-positive glioblastoma by equipping them with a truncated anti-GD2 chimeric antigen receptor (CAR) [50], a strategy that has similarly been used for selectively targeting CAR T cells to GD2-expressing NB cells [51].